Neuro-Oncological Ventral Antigen 1 (NOVA1) Peptide
Quick Overview for Neuro-Oncological Ventral Antigen 1 (NOVA1) Peptide (ABIN8106320)
Target
Source
Application
-
-
Purpose
- NOVA1 Peptide
-
-
Neuro-Oncological Ventral Antigen 1 (NOVA1) peptide
NOVA1 Reactivity: Human Host: Synthetic BP, Imm
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-NOVA1 antibody ( ARP40397_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- NOVA1 (Neuro-Oncological Ventral Antigen 1 (NOVA1))
-
Background
-
Background Information: NOVA1 is a neuron-specific RNA-binding protein, a member of the Nova family of paraneoplastic disease antigens, that is recognized and inhibited by paraneoplastic antibodies. These antibodies are found in the sera of patients with paraneoplastic opsoclonus-ataxia, breast cancer, and small cell lung cancer.This gene encodes a neuron-specific RNA-binding protein, a member of the Nova family of paraneoplastic disease antigens, that is recognized and inhibited by paraneoplastic antibodies. These antibodies are found in the sera of patients with paraneoplastic opsoclonus-ataxia, breast cancer, and small cell lung cancer. Alternatively spliced transcripts encoding distinct isoforms have been described.
Alternative Symbols: Nova-1
-
Molecular Weight
- 52kDa
-
Gene ID
- 4857
-
NCBI Accession
- NP_002506
-
UniProt
- A8K603
Target
-
